Luminist Capital’s GE HealthCare GEHC Stock Holding History

Luminist Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$164	–	176
2025 Q4	$164	Hold	2	–	–	﹤0.01%	269
2025 Q3	$151	Hold	2	–	–	﹤0.01%	329
2025 Q2	$152	Buy	+2	New	+$139	﹤0.01%	335

Other funds holding GEHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Luminist Capital's GEHC Position: Q1 2026 in Review

Luminist Capital sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2 shares — an estimated $164 sold.

Luminist Capital first reported a position in GEHC in Q2 2025 and held it in 3 quarters. The position peaked at $164 in Q4 2025. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Luminist Capital reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
Luminist Capital sold 2 GE HealthCare shares in Q1 2026, an estimated $164.
Luminist Capital first reported a position in GE HealthCare in Q2 2025 and held it in 3 quarters.
Luminist Capital's GE HealthCare position peaked at $164 in Q4 2025.
1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Luminist Capital's 13F filing for Q1 2026, filed 24 Apr 2026.